The first total synthesis of Mer-N5075A (1), a new potential HIV-I protease inhibitor produced from Streptomyces Chromofuscus, was achieved. The synthetic method is available for Mer-N5075A analogues such as α-MAPI (2), GE20372 A (4) and other chemcally modified compounds.
having potential HIV-I protease inhibitory activity. The first total synthesis of 1 and a diastereomeric mixture of 2 and 3 was achieved simply by a route connecting two dipeptides. The synthetic method is applicable for synthesis of Mer-N5075A analogues, such as GE20372 A and B (4 and 5) and other chemically modified compounds. In addition, the inhibition of HIV-1 Protease and anti HIV activity by